Seroprevalence and Risk Factors of Hepatitis B Virus Among Newly Diagnosed Cancer Patients in Khartoum State: Implications for Chemotherapy Management and Screening Protocols
The study reveals a notable HBV seroprevalence among cancer patients in Khartoum, particularly linked to blood transfusion history and specific regions. These findings emphasize the need for routine HBV screening in oncology patients before chemotherapy to prevent reactivation and improve clinical outcomes.
Authors
- Adil Abbas (ORCID: https://orcid.org/0000-0002-6148-3785)
- Abubaker A MohamedSharif (ORCID: https://orcid.org/0000-0002-2600-9666)
- Isra Bdraldein Salih Mohammed (ORCID: https://orcid.org/0000-0003-0655-3653)
- Anwaar Abdulgader Merghani Alkhdir
Institutions
- University of Khartoum (SD)
- University of Bahri (SD)
Publication Details
- Journal
- JGH Open
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/jgh3.70171
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00